97649648 - STARBRIGHT

Information

• Trademark
• 97649648

• Source

• Serial Number

  97649648

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 26, 2022
  a year ago

• Transaction Date

  December 26, 2023
  5 months ago

• Status Date

  December 26, 2023
  5 months ago

• Published for Opposition Date

  October 31, 2023
  7 months ago

• Location Date

  December 26, 2023
  5 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BUSH, KAREN K

• Attorney Docket Number

  1274997

  Attorney Name

  Margaret C. McHugh

  Law Office Assigned Location Code

  L80

• Owners

  • Bio-Rad Laboratories, Inc.

Case File Statements

• GS0401: Treatment of materials by chemical processes; purification of proteins; custom production of bioconjugates, biopolymers, and conjugation reagents for others; custom manufacturing services of goods, namely, chemicals and chemical reagents pertaining to conjugate blocking technology; custom manufacturing services of assays and lateral flow assays pertaining to the enhancement and performance of lateral flow assays
• GS0051: Fluorescent dyes and chemicals for medical use; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for medical purposes; proteins for medical use; cell culture proteins for medical use; monoclonal antibodies for medical use; monoclonal antibodies for in vitro medical use; fluorescent dyes for medical use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; biochemically labelled and enzyme labelled antibodies for medical use; microparticles containing fluorescent dyes for flow cytometry and medical use; chemical and biochemical preparations, assays, dyes, and reagents for clinical and medical laboratory use; chemical reagents for medical purposes for flow cytometry; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical purposes; Chemical reagent for medical purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules. chemicals and chemical reagents for medical use; reagents in kit form for performing assays for medical purposes; chemicals agents for use in separation for medical use; cell culture media for use in separation techniques for medical use; biochemical test kits comprising assays and reagents for medical purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for medical purposes; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for medical purposes; flow cytometry kits comprised of research reagents, buffers and controls for medical purposes
• PM0001: STAR BRIGHT
• GS0011: Fluorescent dyes for scientific or research use; fluorescent dyes for scientific use in life science applications; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for scientific, laboratory, or research purposes; fluorescent dyes for research use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; proteins for scientific and research use; cell culture proteins for scientific and research use; biochemical, namely, monoclonal antibodies for in vitro scientific and research use; biochemically labelled and enzyme labelled antibodies for use in science; microparticles containing fluorescent dyes for flow cytometry and scientific use; enzyme and chemical labelling molecules for use in science; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; assays and reagents for use in scientific, laboratory and research purposes; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; Chemical reagent for research purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules; Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for use in science; reagents in kit form for performing assays for scientific and research use; flow cytometry kits comprised of research reagents, buffers and controls for research laboratory use
• GS0421: Chemical analysis and research for others; medical laboratory services; medical testing for medical, scientific and research purposes; research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Case File Event Statements

• 12/26/2023 - 5 months ago

  21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/31/2023 - 7 months ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/31/2023 - 7 months ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/11/2023 - 8 months ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/25/2023 - 8 months ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/25/2023 - 8 months ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/25/2023 - 8 months ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/25/2023 - 8 months ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/25/2023 - 8 months ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/14/2023 - 9 months ago

  12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 9/5/2023 - 9 months ago

  11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 8/22/2023 - 9 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/8/2023 - 10 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/7/2023 - 10 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/7/2023 - 10 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/7/2023 - 11 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/7/2023 - 11 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/7/2023 - 11 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/3/2023 - 11 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/9/2022 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/29/2022 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP